AKT1 and breast carcinoma: In addition, MA promotes autophagosome formation by inactivating the RIP1-mediated AKT/mTOR signaling pathway and restrains autophagosome degradation by reducing lysosomal acidity, thus inducing secretory autophagy in breast cancer cells.